| RS1187796945 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS1187804477 |
CYP27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestanol storage disease, Cardiovascular phenotype |
| RS1187805545 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, Severe combined immunodeficiency disease |
| RS1187807999 |
INSL3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1187814622 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Inborn genetic diseases |
| RS1187832552 |
FBXL4
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS1187839124 |
CERKL
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 26, Retinal dystrophy |
| RS1187844488 |
GABRA2
|
Health Risk |
Conflicting classifications of pathogenicity |
GABRA2-related disorder, GABRA2-related disorder |
| RS1187849857 |
CCDC40
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 15, Primary ciliary dyskinesia 15 |
| RS1187853717 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1187861686 |
RAB33B
|
Health Risk |
Pathogenic |
Smith-McCort dysplasia 2, Smith-McCort dysplasia 2 |
| RS1187871689 |
ADGRG1
|
Health Risk |
Likely pathogenic |
— |
| RS1187876547 |
CEP83
|
Health Risk |
Pathogenic |
Nephronophthisis 18, Nephronophthisis 18 |
| RS1187887456 |
USH1C
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1C, Autosomal recessive nonsyndromic hearing loss 18A |
| RS1187922643 |
HYOU1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1187924642 |
PPA2
|
Health Risk |
Likely pathogenic |
Sudden cardiac failure, infantile |
| RS1187924885 |
DSG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Arrhythmogenic right ventricular cardiomyopathy, Arrhythmogenic right ventricular dysplasia 10 |
| RS1187943520 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS1187948767 |
ATP2A1
|
Health Risk |
Pathogenic |
Brody myopathy, Brody myopathy |
| RS1187971271 |
IL10RA
|
Health Risk |
Pathogenic |
Inflammatory bowel disease 28, Inflammatory bowel disease 28 |
| RS11879768 |
MYBPC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nonpapillary renal cell carcinoma, Nonpapillary renal cell carcinoma |
| RS1187982748 |
SURF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Mitochondrial complex IV deficiency |
| RS1187991259 |
CERKL
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 26 |
| RS1188006437 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS1188013106 |
BLTP1
|
Health Risk |
Likely pathogenic |
Alkuraya-Kucinskas syndrome, Alkuraya-Kucinskas syndrome |
| RS1188022140 |
SRRM2
|
Health Risk |
Likely pathogenic |
SRRM2-related disorder, SRRM2-related disorder |
| RS1188025733 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1188035446 |
GBA2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 46, Hereditary spastic paraplegia 46 |
| RS1188048436 |
ACO2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1188053375 |
DGUOK
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) |
| RS1188058763 |
GALNT3
|
Health Risk |
Likely pathogenic |
Tumoral calcinosis, hyperphosphatemic |
| RS1188070167 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 16, Hyperkalemic periodic paralysis |
| RS1188080726 |
BSND
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 4A, Bartter disease type 4A |
| RS1188082371 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS1188093917 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1188094714 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lymphangiomyomatosis, Tuberous sclerosis 2 |
| RS1188095865 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS1188099847 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1188106799 |
TBCE
|
Health Risk |
Likely pathogenic |
Hypoparathyroidism-retardation-dysmorphism syndrome, Autosomal recessive Kenny-Caffey syndrome |
| RS1188116333 |
MANBA
|
Health Risk |
Pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS1188117543 |
BOD1
|
Health Risk |
Pathogenic |
— |
| RS1188156028 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1188175909 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS1188195580 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1188199694 |
FREM1
|
Health Risk |
Likely pathogenic |
— |
| RS1188206999 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Inborn genetic diseases |
| RS11882073 |
MYH14
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1188227820 |
DNAI1
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1188230416 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1188233243 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystrophin deficiency, Becker muscular dystrophy |
| RS1188239387 |
NKX2-5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Atrial septal defect 7 |
| RS1188244229 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1188250699 |
DUOX2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1188257054 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS1188265182 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Inborn genetic diseases |
| RS1188265845 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS1188281491 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 39 |
| RS1188292999 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1188297697 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1188300105 |
STEEP1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 107 |
| RS1188306380 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1188310172 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1188323449 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS1188328539 |
ALMS1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS1188352454 |
TMEM106B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1188358849 |
CRELD1
|
Health Risk |
Pathogenic |
Atrioventricular septal defect, susceptibility to |
| RS1188370836 |
DDX3X
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1188399385 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1188417345 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS1188426077 |
TFR2
|
Health Risk |
Pathogenic |
Hereditary hemochromatosis, Hereditary hemochromatosis |
| RS1188435532 |
DDR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome, Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome |
| RS1188437940 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1188440303 |
CCDC40
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 15, Primary ciliary dyskinesia 15 |
| RS1188461028 |
LZTR1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1188488324 |
TONSL
|
Health Risk |
Pathogenic |
— |
| RS1188496776 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 6 |
| RS1188500920 |
CHMP1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1188506084 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile hypophosphatasia, Adult hypophosphatasia |
| RS1188507108 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS1188515677 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Age related macular degeneration 2 |
| RS1188527089 |
SPTBN2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1188540819 |
LTBP3
|
Health Risk |
Pathogenic |
Geleophysic dysplasia 3, Geleophysic dysplasia 3 |
| RS1188549864 |
DDX41
|
Health Risk |
Likely pathogenic |
— |
| RS1188555703 |
BRAT1
|
Health Risk |
Pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1188556155 |
CLCN7
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteopetrosis, Osteopetrosis |
| RS1188559992 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1188561568 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 2, Autosomal recessive nonsyndromic hearing loss 2 |
| RS1188561908 |
CPLANE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome 17 |
| RS1188569102 |
NOTCH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral arteriopathy, autosomal dominant |
| RS1188581065 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1188584832 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1188591008 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1188592346 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1188601783 |
LRP2
|
Health Risk |
Likely pathogenic |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS1188616455 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS1188637368 |
MYO7A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS1188643869 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
PKD1-related disorder, Polycystic kidney disease |
| RS1188649369 |
TMEM67
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1188654362 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1188663543 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |